Cadrenal Therapeutics Inc. Common Stock
CVKD | NASDAQ
$1.09
$0 (0.00%)
Sep 22, 2026, 1:19 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Net Income | -13.24M | -10.65M | -8.36M | -7.32M |
Depreciation & Amortization | 6.87K | 1.88K | 1.98K | 74.38K |
Stock-Based Compensation | 1.94M | 1.42M | 710.38K | 1.01M |
Other Working Capital | -492.33K | 538.1K | 381.89K | 221.28K |
Other Non-Cash Items | n/a | -352 | 3.97M | 4.7M |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.31M | 1.87M | 144.31K | 221.28K |
Operating Cash Flow | -12.6M | -7.36M | -3.53M | -1.31M |
Capital Expenditures | -5.1K | -6.54K | -3.25K | -2.49K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | -5.1K | -6.54K | -3.25K | -2.49K |
Debt Repayment | n/a | n/a | -250K | n/a |
Common Stock Repurchased | -291.88K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -271.21K | 3.84M | 250K | 1.35M |
Financial Cash Flow | 6.6M | 8.98M | 11.9M | 1.35M |
Net Cash Flow | -6.01M | 1.62M | 8.37M | 32.59K |
Free Cash Flow | -12.6M | -7.36M | -3.53M | -1.32M |
Adj. Free Cash Flow | -14.54M | -8.78M | -4.24M | -2.33M |
Maintenance CapEx | -5.1K | -1.88K | -1.98K | -2.49K |
Growth CapEx | n/a | -4.66K | -1.27K | n/a |
Owner Earnings | -12.61M | -7.36M | -3.53M | -1.32M |
Add to Watchlist
Select watchlists to add or remove CVKD